Aurora Cannabis Comprehensive Income 2017-2024 | ACB
Aurora Cannabis comprehensive income from 2017 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
| Aurora Cannabis Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-153 |
| 2022 | $-167 |
| 2021 | $-162 |
| 2020 | $-140 |
| 2019 | $-108 |
| 2018 | $-0 |
| 2017 | $ |
| 2017 | $ |
| 2016 | $ |
| Aurora Cannabis Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-152 |
| 2024-03-31 | $-153 |
| 2023-12-31 | $-155 |
| 2023-09-30 | $-158 |
| 2023-06-30 | $-157 |
| 2022-12-31 | $-156 |
| 2022-09-30 | $-160 |
| 2022-03-31 | $-164 |
| 2021-12-31 | $-168 |
| 2021-09-30 | $-167 |
| 2021-03-31 | $-162 |
| 2020-12-31 | $-157 |
| 2020-09-30 | $-147 |
| 2020-03-31 | $-136 |
| 2019-12-31 | $-130 |
| 2019-09-30 | $-123 |
| 2019-03-31 | $-70 |
| 2018-12-31 | $-121 |
| 2018-09-30 | $4 |
| 2018-06-30 | $-0 |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.262B | $0.200B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $202.584B | 25.84 |
| Stryker (SYK) | United States | $144.427B | 32.55 |
| Boston Scientific (BSX) | United States | $130.404B | 37.49 |
| Medtronic (MDT) | Ireland | $113.203B | 16.84 |
| EssilorLuxottica (ESLOY) | France | $112.107B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.279B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| GE HealthCare Technologies (GEHC) | United States | $39.012B | 20.24 |
| ResMed (RMD) | United States | $36.507B | 30.00 |
| Terumo (TRUMY) | Japan | $30.649B | 43.28 |
| Koninklijke Philips (PHG) | Netherlands | $24.871B | 19.04 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.791B | 13.87 |
| Insulet (PODD) | United States | $19.339B | 77.01 |
| Baxter (BAX) | United States | $17.458B | 11.37 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.816B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.245B | 34.82 |
| BellRing Brands (BRBR) | United States | $9.218B | 38.97 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.846B | 13.58 |
| TG Therapeutics (TGTX) | United States | $4.785B | 0.00 |
| Haemonetics (HAE) | United States | $4.590B | 22.40 |
| ICU Medical (ICUI) | United States | $4.354B | 41.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 20.09 |
| Perrigo (PRGO) | Ireland | $3.645B | 10.73 |
| Envista Holdings (NVST) | United States | $3.571B | 26.60 |
| Neogen (NEOG) | United States | $3.554B | 41.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.448B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $3.068B | 19.67 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.891B | 18.61 |
| LeMaitre Vascular (LMAT) | United States | $2.372B | 57.65 |
| Warby Parker (WRBY) | United States | $2.084B | 0.00 |
| AtriCure (ATRC) | United States | $1.862B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.651B | 28.90 |
| InMode (INMD) | Israel | $1.638B | 9.85 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.458B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.405B | 10.05 |
| BioLife Solutions (BLFS) | United States | $1.227B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.079B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 18.25 |
| Owens & Minor (OMI) | United States | $1.031B | 8.05 |
| CeriBell (CBLL) | United States | $0.983B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.931B | 31.10 |
| Capricor Therapeutics (CAPR) | United States | $0.887B | 0.00 |
| Evolus (EOLS) | United States | $0.831B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.598B | 18.04 |
| Quanterix (QTRX) | United States | $0.588B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.546B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.508B | 0.00 |
| Valneva SE (VALN) | France | $0.417B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.19 |
| Canopy Growth (CGC) | Canada | $0.379B | 0.00 |
| Cerus (CERS) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.370B | 35.22 |
| OraSure Technologies (OSUR) | United States | $0.316B | 21.20 |
| Biote (BTMD) | United States | $0.312B | 14.38 |
| Sanara MedTech (SMTI) | United States | $0.306B | 0.00 |
| Zynex (ZYXI) | United States | $0.296B | 62.00 |
| MacroGenics (MGNX) | United States | $0.276B | 0.00 |
| Jin Medical (ZJYL) | China | $0.250B | 0.00 |
| Omeros (OMER) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 16.05 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| TerrAscend (TSNDF) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.180B | 216.00 |
| Organigram Holdings (OGI) | Canada | $0.169B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.99 |
| Rockwell Medical (RMTI) | United States | $0.144B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.140B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.117B | 0.00 |
| Veru (VERU) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 9.76 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.20 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.081B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.69 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.066B | 0.00 |
| Safety Shot (SHOT) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.055B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.053B | 0.00 |
| Exagen (XGN) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.60 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |